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Abstract 
Iontophoresis of 1-adrenoceptor agonists in the human forearm evoke axon reflex 
vasodilatation, possibly due to an accumulation of inflammatory agents at the site of 
iontophoresis. To investigate this possibility, skin sites in the forearm of healthy 
participants were treated with an anti-inflammatory gel containing ibuprofen 5% 
before the iontophoresis of the 1-adrenoceptor agonist phenylephrine (350 µA for 3 
minutes). Red cell flux was measured with laser Doppler flowmetry at the site of 
iontophoresis and 8 mm away in the region of axon reflex vasodilatation. In additional 
experiments, skin sites were treated with the vasodilator sodium nitroprusside (to 
counteract vasoconstriction and disperse inflammatory mediators produced during the 
iontophoresis of phenylephrine); local anaesthetic agent (to determine whether the 
axon reflex to phenylephrine was neurally-mediated); or the 2-adrenoceptor agonist 
clonidine (to investigate the specificity of the adrenergic axon reflex). Phenylephrine 
evoked marked vasodilatation 8 mm from the site of iontophoresis whereas clonidine 
and saline-control did not (mean flux increase + S.E. 485 + 132% for phenylephrine; 
44 + 24% for clonidine; 39 + 19% for saline-control; p<0.05 for phenylephrine versus 
control). Axon reflex vasodilatation to phenylephrine was unaffected by variations in 
blood flow at the site of phenylephrine iontophoresis, but was reduced by ibuprofen 
pretreatment and abolished by local anaesthetic pretreatment. These findings suggest 
that prostaglandin synthesis at the site of iontophoresis contributes to but does not 
account entirely for axon reflex vasodilatation to phenylephrine. Alpha-1 
adrenoceptor mediation of axon reflexes could play a role in aberrant sensory-
sympathetic coupling in neuro-inflammatory diseases.    3 
Introduction 
  Stimulation of 1-adrenoceptors generally increases neural discharge in the 
dorsal horn of the spinal cord whereas 2-adrenoceptor stimulation is inhibitory 
(Holden et al., 1999; Pertovaara, 2006). This has implications for pain control, as 
inhibitory 2- effects of noradrenaline usually outweigh excitatory 1- influences on 
spinal and supra-spinal nociceptive neurotransmission. 
 The effects of -adrenoceptor stimulation on peripheral nociceptive afferents 
are less clear. In uninjured animals, neither stimulation of the sympathetic chain nor 
close arterial injection of noradrenaline had any discernable effect on activity of C-
fibre nociceptors (Sato and Perl, 1991). Similarly, in humans, sympathetic activity did 
not affect neural discharge of C-fibre cutaneous nociceptive afferents primed with 
mustard oil (Elam et al., 1999). Nevertheless, there is evidence that 1-adrenoceptors 
influence nociceptive discharge. For example, in uninjured rats blockade of 1-
adrenoceptors inhibited behavioural signs of pain induced by subcutaneous injection 
of the 1-adrenoceptor agonist phenylephrine and β-methylene-ATP (an agonist for 
purinergic P2X3 receptors) (Meisner et al., 2007), whereas blockade of 2-
adrenoceptors was ineffective. Similarly, blockade of 1- but not 2-adrenoceptors 
abolished hyperalgesia and C-fibre discharge evoked by intradermal injection of 
capsaicin (Kinnman and Levine; 1995; Ren et al., 2005). In studies on healthy 
humans, intradermal injection of 1- and 2-adrenergic agonists increased sensitivity 
to heat-pain (Fuchs et al., 2001), as did iontophoresis of noradrenaline and 
phenylephrine in mildly burnt or inflamed skin (Drummond, 1995; Drummond, 1998; 
Drummond, 2009a).  
Animal studies have shown that 1-adrenoceptors may also influence the flare 
that develops around the site of inflammation and injury (Lin et al., 2003). The flare is   4 
thought to be mediated by neural discharge that spreads retrogradely through the 
terminal network of mechano-insensitive nociceptive C-fibres (termed an axon 
reflex), ultimately releasing neuropeptides that act on mast cells, immune cells and 
vascular smooth muscle to increase local blood flow (Schmelz et al., 2000; Schmelz 
and Petersen, 2001; Richardson and Vasko, 2002). Intradermal administration of 
noradrenaline by microdialysis on the dorsal aspect of the human hand did not induce 
axon reflex vasodilatation (Zahn et al., 2004). Nevertheless, iontophoresis of 
noradrenaline evoked an axon reflex in the human forearm that was blocked by 
pretreatment with a local anaesthetic cream (Drummond and Lipnicki, 1999), and 
iontophoresis of the 1-adrenoceptor agonist methoxamine evoked vasodilatation in 
nearby skin that was blocked by pretreatment with the 1-adrenoceptor antagonist 
terazosin (Drummond 2009b).  
Together, these findings suggest that 1-adrenoceptors modulate the 
sensitivity of peripheral C-fibre nociceptors, either directly (Nicholson et al., 2005) or 
by releasing inflammatory agents such as nerve growth factor or prostaglandin E2 
from secondary target cells (Tuttle et al., 1993; Trevisani et al., 2007; Kopp et al., 
2007). Adrenergic vasoconstriction (Drummond, 2002; Thompson et al., 2005) might 
intensify these effects by reducing the dispersal of inflammatory mediators. 
To investigate the mechanism of adrenergic axon reflex vasodilatation in the 
present study, a gel containing the anti-inflammatory agent ibuprofen was applied to 
the skin before iontophoresis of the 1-adrenoceptor agonist phenylephrine. In 
addition, blood flow in the skin of the human forearm was manipulated by local 
treatment with sodium nitroprusside, a nitric oxide donor that directly relaxes vascular 
smooth muscle and opposes adrenergic vasoconstriction in human skin (Shibasaki et 
al., 2008). It was hypothesized that local vasodilatation at the site of phenylephrine   5 
administration would reduce the axon reflex to phenylephrine by promoting the 
dispersal of inflammatory mediators. Additional aims were: (1) to determine whether 
pretreatment of the skin with local anaesthetic agent blocked the axon reflex to 
phenylephrine (thereby confirming that the response was neurally-mediated); and (2) 
to establish whether iontophoresis of the 2-adrenoceptor agonist clonidine induced 
an axon reflex (to investigate the specificity of the response to -adrenergic agonists). 
Method 
Participants and ethics approval 
  The sample consisted of 13 healthy men and 18 healthy women aged between 
18 and 70 years. They each provided written informed consent for the procedures, 
which conformed to standards set by the Declaration of Helsinki and that were 
approved by the Murdoch University Human Research Ethics Committee. 
Procedures  
The experiments were carried out in a temperature-controlled laboratory 
maintained at 22 + 1
oC.  
Drugs for iontophoresis. Phenylephrine hydrochloride (1-adrenoceptor 
agonist), clonidine hydrochloride (2-adrenoceptor agonist), and sodium nitroprusside 
(a nitric oxide donor) were purchased from Sigma-Aldrich (Sydney, Australia). They 
were dissolved in de-ionized water (Turner et al., 2008) at 10 mM. To minimize 
degradation by light, sodium nitroprusside was stored in darkness and vials were 
wrapped in aluminium foil.  
Introduction of drugs into the skin. Perspex iontophoresis capsules with an 
internal chamber diameter of 10 mm were attached with adhesive washers to the 
dorsal aspect of the left or right forearm, and a 3 cm x 5 cm silver plate was attached 
to the wrist to complete the electrical circuit. Cotton swabs soaked with 0.9% saline   6 
were placed under the plate electrode to enhance electrical contact with the skin. To 
ensure that the capsule adhered firmly and that good electrical contact was made, 
forearm sites were shaved, if necessary, and cleaned with an isopropyl alcohol swab. 
Care was taken not to touch the skin with the razor while the hair was being removed. 
The Perspex chamber was filled with a drug solution and a constant direct current was 
passed through the solution to introduce the ionized drug into the skin. Experimental 
sites on the same forearm were separated by at least 5 cm. 
Vascular responses were monitored at the site of drug administration via the 
wide surface area DP7a probe of a Moor Instruments MBF3D laser Doppler 
flowmeter (Axminster, England) inserted into the roof of the iontophoresis chamber 
(direct reponse). A second probe detected changes in skin blood flow 8 mm from the 
outer rim of the chamber, in the region of axon reflex vasodilatation.  
Responses to -adrenoceptor agonists. In nine participants a constant current 
of 350 µA was passed through each drug solution for three minutes to introduce 
positively-charged phenylephrine or clonidine ions into the skin (Drummond and 
Lipnicki, 1999). Skin blood flow was monitored for several minutes before each 
procedure, during the iontophoresis, and for five minutes afterwards. To measure the 
nonspecific effects of iontophoresis, 350 µA was also passed through a 0.9% saline 
solution for three minutes. Saline was used instead of de-ionized water to match the 
low electrical resistance of ionized drugs in solution (Khan et al., 2004). 
Effect of pretreatment with an anti-inflammatory gel on vascular responses to 
phenylephrine. Nurofen gel (ibuprofen 5%) (Reckitt Benchiser, Sydney Australia) 
was rubbed into a 10 mm diameter site on each forearm of 14 participants for 1 
minute. To investigate nonspecific effects, a conductive gel used for ultrasound and 
electrocardiograph recordings (Medical Equipment Services, Melbourne, Australia)   7 
was rubbed into additional sites on each forearm. Capsules (10 mm internal diameter) 
were then filled with the appropriate gel and taped to the four prepared sites for 60 
minutes. The capsules were then removed and excess gel was gently wiped from the 
skin. Topical application produces a high intradermal concentration of ibuprofen but 
only a minor fraction (< 1%) enters the plasma or urine (Tegeder et al., 1999). 
Iontophoresis capsules (internal diameter 10 mm) were placed over the treated sites 
and skin blood flow was monitored for two minutes from a probe housed within the 
iontophoresis chamber and another probe 8 mm away from the treated area. A direct 
current of 350 µA was then passed through 10 mM phenylephrine or a nonspecific 
conducting medium (0.9% saline) in the iontophoresis chamber for three minutes at 
the sites pretreated with the ibuprofen or conductive gel. Skin blood flow was 
monitored during the iontophoresis and for a further five minutes afterwards. Straight 
after each iontophoresis, participants were asked to rate the pain they had just 
experienced on a 0-10 scale where 0 corresponded to “no pain at all” and 10 to 
“extremely painful”.   
Effect of pretreatment with local anaesthetic agent on vascular responses to 
phenylephrine. EMLA cream (lignocaine 2.5% and prilocaine 2.5%) (AstraZeneca, 
Sydney, Australia) and a cream containing 10% glycerol (sorbolene cream; Coles 
Supermarkets, Australia) were placed in 10 mm diameter capsules and glued lightly to 
the forearm of nine participants for at least 100 minutes. The capsules were then 
removed and excess cream was gently wiped from the skin. Sensory tests confirmed 
that sites pre-treated with EMLA cream were insensitive to tactile stimulation whereas 
sensations remained unchanged at the sorbolene sites. Skin blood flow responses to 
iontophoresis of phenylephrine (350 µA for 3 minutes) were then monitored, as 
above.    8 
Effect of sodium nitroprusside on responses to phenylephrine. In eight 
participants, a current of 50 µA was passed through a solution of sodium nitroprusside 
for two minutes to introduce negatively-charged nitroprusside ions into the skin 
(Drummond, 1999). Vascular responses to the nitroprusside were monitored for a 
further five minutes. To control for the nonspecific effects of iontophoresis, the 
procedure was repeated at another site with 0.9% saline. Next, the nitroprusside and 
saline solutions were replaced with a phenylephrine solution. Skin blood flow was 
monitored for two minutes to establish a baseline, after which a current of 350 µA 
was passed through the phenylephrine solution for three minutes to introduce 
positively-charged phenylephrine ions into the skin. Vascular responses were 
monitored during the iontophoreses and for five minutes afterwards. In nine other 
participants, the order of the procedures was reversed (i.e., nitroprusside and saline-
control were administered after the iontophoresis of phenylephrine). 
Data reduction and statistical approach 
  Vascular responses generally began during the first minute of iontophoresis 
and peaked during the subsequent 5-minute period of monitoring. Hence, mean flux 
(the low-frequency component of the laser Doppler signal reflecting tissue perfusion 
to a depth of 1-2 mm) was measured minute-by-minute starting 1 minute before the 
iontophoresis. As flux was recorded in arbitrary units, responses during and after the 
iontophoresis were expressed as the percent change from levels at baseline. 
  Effects were investigated in Drug Treatment (active versus control) x Time 
(minute-by-minute changes in flux) analyses of variance for repeated measures using 
SPSS version 17 software. Where appropriate, the degrees of freedom were adjusted 
with the Greenhouse-Geisser epsilon to correct for violations of the sphericity 
assumption. Data are presented as the mean + S.E.    9 
Results 
Responses to -adrenoceptor agonists 
  Direct response at the site of drug administration. Increases in flux at sites of 
phenylephrine and clonidine iontophoresis were similar to the increase at the site of 
saline iontophoresis (Figure 1A). 
  Axon reflex 8 mm from the site of drug administration. The flux increase 8 mm 
from sites of phenylephrine iontophoresis greatly exceeded the minor increase after 
saline iontophoresis [main effect for Drug F(1,8) = 10.5, p<0.05, Drug x Time 
F(1.7,13.3) = 11.6, p<0.01] (Figure 1B). The minor increase in flux after the clonidine 
iontophoresis was similar to the minor increase after the saline iontophoresis (Figure 
1B). 
Effect of pretreatment with the ibuprofen gel on pain ratings and vascular responses to 
phenylephrine and saline-control 
Pain ratings. Pain experienced during iontophoresis was greater for sites 
pretreated with the conductive gel than for sites pretreated with ibuprofen [main effect 
for pretreatment F(1,13) = 4.94, p<0.05] (Table 1). However, pain ratings were 
similar for phenylephrine and saline-control.   
Direct response at the site of drug administration. Pretreatment with the 
ibuprofen gel blocked increases in flux to the iontophoresis of phenylephrine 
[ibuprofen versus conductive gel pretreatment F(1,13) = 18.9, p<0.001] (Figure 2A) 
and saline [ibuprofen versus conductive gel pretreatment F(1,13) = 7.70, p<0.05] 
(Figure 2B). 
 Axon reflex 8 mm from the site of drug administration. In general, 
pretreatment with the ibuprofen gel reduced but did not abolish increases in flux after 
the phenylephrine iontophoresis (Figure 3A). However, in one exceptional case, flux   10 
increased 391% after the phenylephrine iontophoresis at the site pretreated with 
ibuprofen compared with 223% at the site pretreated with the conductive gel. As the 
increase in flux at the ibuprofen site was more than three standard deviations greater 
than the mean response in the group as a whole, the analysis was repeated after 
excluding data from this participant. In the remaining participants, the ibuprofen 
pretreatment inhibited increases in flux 8 mm from the site of phenylephrine 
iontophoresis [mean increase at the site of ibuprofen pretreatment 40 + 15% compared 
with 144 + 40% at the site of pretreatment with conductive gel; ibuprofen versus 
conductive gel pretreatment F(1,12) = 4.84, p<0.05]. Despite the inhibitory influence 
of the ibuprofen pretreatment, iontophoresis of phenylephrine still evoked greater 
increases in flux than iontophoresis of saline [40 + 15% for phenylephrine versus -3 + 
3% for saline at sites pretreated with ibuprofen F(1,12) = 9.08, p<0.05]. The ibuprofen 
pretreatment did not affect vascular responses to the saline iontophoresis (Figure 3B). 
Effect of local anaesthetic agent on vascular responses to phenylephrine 
  Direct response at the site of drug administration. Pretreatment either with 
EMLA or sorbolene cream blocked increases in flux at the site of phenylephrine 
iontophoresis [mean increase at the site of EMLA pretreatment 23 + 13% compared 
with 63 + 20% at the site of sorbolene pretreatment and 244 + 71% at a site that 
received no pretreatment; EMLA versus no pretreatment F(1,8) = 8.53, p<0.05; 
sorbolene versus no pretreatment F(1,8) = 9.16, p<0.05] (Figure 4A). Residual 
increases in flux to phenylephrine did not differ significantly between the EMLA and 
sorbolene sites. 
  Axon reflex 8 mm from the site of drug administration. Increases in flux after 
the phenylephrine iontophoresis were similar at the untreated and sorbolene pretreated 
sites (Figure 4B). However, pretreatment with EMLA cream blocked increases in flux   11 
[EMLA versus sorbolene pretreatment F(1,8) = 11.9, p<0.01; Pretreatment x Time 
F(1.3, 10.1) = 9.73, p<0.01] (Figure 4B).  
Effect of sodium nitroprusside on responses to phenylephrine  
  Effect of nitroprusside in untreated skin. The direct response was markedly 
greater at the site of nitroprusside iontophoresis than at the site of saline 
iontophoresis, and persisted for at least five minutes after the iontophoresis 
[nitroprusside versus saline F(1,7) = 46.2, p<0.001; Drug x Time F(1.2,8.1) = 32.5, 
p<0.001) (Figure 5A). However, axon reflexes 8 mm from the site of drug 
administration were minimal after both the nitroprusside and saline iontophoreses 
(Figure 5B). 
Effect of nitroprusside pretreatment on responses to phenylephrine. Flux 
decreased during and after the phenylephrine iontophoresis at the site of nitroprusside 
pretreatment, but increased at the site of saline pretreatment [Drug x Time F(2.4,16.5) 
= 18.8, p<0.001] (Figure 6A). The nitroprusside pretreatment had no effect on axon 
reflex vasodilatation to phenylephrine 8 mm from the site of drug treatment (Figure 
6B). 
Effect of nitroprusside administered after the phenylephrine iontophoresis. 
The direct response increased after nitroprusside iontophoresis but decreased after 
saline iontophoresis at sites pretreated with phenylephrine [Drug x Time F(1.1,8.7) = 
10.5, p<0.01] (Figure 7A). However, the increase in flux to nitroprusside was smaller 
at sites pretreated with phenylephrine than at untreated sites [maximum increase 481 
+ 118% after phenylephrine pretreatment compared with 838 + 112% without 
phenylephrine pretreatment, t(15) = 2.18, p<0.05] (Figures 5A and 7A). The 
nitroprusside iontophoresis did not alter axon reflex vasodilatation 8 mm from the site 
of drug administration (Figure 7B).   12 
Discussion 
The aims of this experiment were: (1) to determine whether inflammatory 
mediators, together with variation in blood flow at the site of phenylephrine 
administration, affected the axon reflex to phenylephrine; (2)  to establish whether 
pretreatment of the skin with local anaesthetic agent blocked axon reflex 
vasodilatation to phenylephrine (thereby confirming that the response was neurally-
mediated); and (3) to determine whether iontophoresis of the 2-adrenoceptor agonist 
clonidine induced an axon reflex (to investigate the specificity of the response to -
adrenergic agonists). Introduction of the 1-adrenoceptor agonist phenylephrine into 
the skin by iontophoresis evoked axon reflex vasodilatation that was reduced by 
pretreatment with an anti-inflammatory gel and abolished by local anaesthetic agent. 
However, axon reflex vasodilatation to phenylephrine was unaffected by blood flow 
at the site of drug administration, and axon reflex vasodilatation was minimal after 
iontophoresis of the 2-adrenoceptor agonist clonidine.  
Direct responses at the site of drug administration  
  Intradermal administration of noradrenaline through microdialysis fibres 
induces vasoconstriction (Thompson et al., 2005). Nevertheless, blood flow increased 
at the site of iontophoresis of adrenergic agonists in the present study. The passage of 
electric currents through the skin initiates local prostaglandin synthesis (Ferrell et al., 
2002; Durand et al., 2002; Tartas et al., 2005) which, in turn, induces vasodilatation 
(Neisius et al., 2002). Ibuprofen is a non-steroidal analgesic and anti-inflammatory 
agent that inhibits the synthesis of prostaglandins by blocking the cyclo-oyxgenase 
enzyme system (Hersh et al., 2000). When applied as a gel, ibuprofen inhibits the pain 
of soft tissue injuries (Machen and Whitefield, 2002) and inhibits allodynia around the 
heated site of topical capsaicin administration (McCormack et al., 2000). In the   13 
present study, pretreatment with ibuprofen gel inhibited pain and vasodilatation at the 
site of iontophoresis, suggesting that prostanoids contributed to these responses. 
Presumably floor effects or vasodilatation to the prostanoids masked vasoconstriction 
to phenylephrine and clonidine (Lipnicki and Drummond, 2001; Drummond, 2002). 
Nevertheless, it seems likely that the adrenergic agents altered local perfusion because 
phenylephrine opposed vasodilatation to sodium nitroprusside (see also Shibasaki et 
al., 2008). Moreover, the skin remained blanched for up to an hour at sites of 
phenylephrine or clonidine iontophoresis. 
Topical pretreatment with EMLA cream inhibited direct responses and axon 
reflexes to phenylephrine. The local anaesthetic agents in EMLA cream block axon 
reflexes (Morris and Shore, 1996), and could also prevent intraneural prostaglandin 
formation (Richardson and Vasko, 2002). Sorbolene pretreatment also inhibited the 
local vasodilator response to phenylephrine, but not the axon reflex. Similarly, topical 
application of the conductive gel appeared to inhibit local vasodilatation during the 
phenylephrine and saline iontophoreses (see Figures 1 and 2). The mechanism of this 
inhibitory effect requires further investigation, but one possibility is that emollients in 
the gel and cream reduced heat generation or prostaglandin synthesis during the 
passage of ions through the skin (e.g., by increasing hydration of the stratum 
corneum) (Breternitz et al., 2008). In any case, the finding that the sorbolene 
pretreatment inhibited vasodilatation at the site of phenylephrine iontophoresis, 
without affecting vasodilatation in surrounding skin, clearly illustrates the dissociation 
between these two responses. 
Axon reflex vasodilatation 8 mm from the site of drug administration 
  Iontophoresis of phenylephrine provoked marked increases in skin blood flow 
8 mm from the site of drug administration. The response was reduced by ibuprofen   14 
pretreatment, indicating the involvement of prostanoids, and was blocked by prior 
treatment of the skin with EMLA cream, indicating the participation of cutaneous 
nerves. However, the response was unaffected by blood flow at the site of 
phenylephrine iontophoresis. Specifically, pretreatment with sorbolene cream 
inhibited increases in blood flow at the site of phenylephrine iontophoresis but had no 
effect on the axon reflex 8 mm away. Moreover, local vasodilatation induced by 
nitroprusside neither prevented nor reversed responses 8 mm from the site of 
phenylephrine iontophoresis, despite overcoming adrenergic vasoconstriction at the 
site of iontophoresis. Together, the findings suggest that the iontophoresis of 
phenylephrine generated an axon reflex by a mechanism that involved prostanglandin 
synthesis but that did not depend on blood flow at the site of drug administration. 
Importantly, the ibuprofen pretreatment reduced but did not abolish the axon reflex to 
phenylephrine, suggesting the involvement of an additional mechanism. 
Pelvic administration of noradrenaline increases afferent renal nerve activity 
and increases renal pelvic release of substance P and prostaglandin E2 by activating 
1-adrenoceptors on or close to renal pelvic sensory nerve fibres (Kopp et al., 2007). 
In turn, prostaglandin E2 enhances the responsiveness of renal sensory nerves to 
activation of these 1-adrenoceptors. Phenylephrine mobilizes intracellular calcium 
ions in cultured dorsal root ganglia neurons, evokes the release of substance P from 
the peripheral and spinal terminals of nociceptive neurons, and induces neurogenic 
inflammation in the urinary bladder by an 1-adrenoceptor mechanism (Trevisani et 
al., 2007), indicating that 1-adrenoceptors are functionally expressed on primary 
nociceptive afferents. Together, these findings suggest that activation of 1-
adrenoceptors on primary nociceptive afferents increases neural discharge and 
sensitizes nociceptors via synthesis of prostaglandin E2. Similar mechanisms may   15 
account for the inhibitory influence of ibuprofen on axon reflex vasodilatation to 
phenylephrine detected in the present study.  
  Iontophoresis of noradrenaline evokes an axon reflex in human skin 
(Drummond and Lipnicki, 1999) whereas intradermal administration of noradrenaline 
through microdialysis fibres does not (Zahn et al., 2004). Thus, the method of 
intradermal drug delivery appears to be an important element of the adrenergic axon 
reflex. Both heat-evoked neural discharge of noradrenaline and intradermal 
administration of noradrenaline through microdialysis fibres lower the threshold of 
the axon reflex to slow or rapid local heating (Houghton et al., 2006; Hodges et al., 
2008; Hodges et al., 2009). Thus, nociceptive activity generated by heat, or directly 
by electric currents during iontophoresis, might facilitate axon reflexes to 
noradrenaline. In addition, sensitization of primary sensory afferents to an 
inflammatory mediator such as prostaglandin E2 (Lin et al., 2006; Kopp et al., 2007; 
Trevisani et al., 2007) could potentiate responses to 1-adrenoceptor stimulation.  
  In contrast to phenylephrine, axon reflex vasodilatation was minimal after the 
iontophoresis of the 2-adrenoceptor agonist clonidine. In uninjured animals, 
clonidine inhibits the depolarization of primary nociceptive afferents. For example, 
clonidine inhibited mobilization of intracellular calcium ions to electric field 
stimulation in acutely dissociated nociceptive neurons (Eisenach et al., 2005), and 
impeded the nociceptive withdrawal reflex elicited by sural nerve stimulation 
(Gozariu et al., 1996). Clonidine also inhibited the wheal and flare reaction to 
intradermal antigen injection in guinea-pig skin by an 2-adrenoceptor mechanism 
(Lindgren et al., 1987), but whether this involved an inhibitory effect on mast cells, 
immune cells or cutaneous nerves is uncertain. In contrast to stimulation of 1-
adrenoceptors, activation of 2-adrenoceptors on or close to renal pelvic sensory   16 
nerve fibres decreased pelvic prostaglandin E2 synthesis and inhibited depolarization 
of these nerves (Kopp et al., 2007). Thus, it is not surprising that clonidine did not 
initiate axon reflex vasodilatation in the present study.   
  The nitric oxide donor nitroprusside evoked substantial increases in blood 
flow at the site of administration but did not generate an axon reflex. Among other 
properties, nitric oxide relaxes vascular smooth muscle (accounting for increases in 
blood flow at the site of nitroprusside administration), contributes to the wheal and 
flare to intradermal injection of histamine (Clough, 1999), and enhances the release of 
neuropeptides from C-fibre terminals (Garry et al., 1994). Although nitric oxide may 
be involved in the expression of axon reflexes, the present findings suggest that nitric 
oxide does not initiate these reflexes. 
  Although phenylephrine evoked greater axon reflex vasodilatation than saline, 
pain ratings did not differ between the two conditions. In human skin, axon reflex 
vasodilatation is thought to be mediated by a subset of nociceptive C-fibres that 
become responsive to mechanical and/or heat stimulation only after sensitization 
(Schmelz et al., 2000). In general, pain ratings were low and some of the participants 
described the sensations experienced during the iontophoreses as a sharp feeling or an 
itch rather than pain. Nevertheless, phenylephrine increases sensitivity to heat-pain in 
mildly burnt skin (Drummond, 2009a); conversely, depletion of cutaneous adrenergic 
stores inhibits electrically-evoked pain in mildly burnt skin (Drummond, 2008). 
Similarly, the nociceptive effects of noradrenaline are greater in skin sensitized by 
capsaicin than in untreated skin (Drummond, 1998). Thus, chemical or thermal 
sensitization of sensory afferents might increase the nociceptive effect of 1-
adrenoceptor stimulation. 
   17 
Limitations 
  To minimize potential influences of skin heating on axon reflexes (Minson et 
al., 2002; Houghton et al., 2006), skin temperature was not controlled in this study. 
Thus, sympathetic vasoconstrictor tone in the region of axon reflex vasodilatation 
may have inhibited axon reflexes in some cases. Another limitation was that hormonal 
changes across the menstrual cycle might have affected skin blood flow and axon 
reflex vasodilatation (Charkoudian, 2001) as the majority of participants were healthy 
young women. Nevertheless, such effects must have been small because 
phenylephrine induced substantial axon reflex vasodilatation. Axon reflexes to local 
heat are smaller in older than younger people, due to diminished release of vasoactive 
neuropeptides or to a diminished responsiveness of the vasculature to these 
neuropeptides (Minson et al., 2002). Most of the participants in the present study were 
young adults. Whether axon reflex vasodilatation to adrenergic agonists declines with 
age requires further investigation. Finally, axon reflex vasodilatation was measured at 
only one location 8 mm from the site of drug administration. Axon reflex 
vasodilatation differs between the superficial and deep layers of skin, and begins at 
distinct spots that may reflect the geometry of deep arterioles which supply the 
surrounding tissue (Forster et al., 1995). Thus, laser Doppler imaging could provide a 
more representative picture of the distribution of adrenergic axon reflex vasodilatation 
than spot measures of blood flow.  
Conclusions and significance 
  Stimulation of 1-adrenoceptors induced an axon reflex that depended, in part, 
on synthesis of prostaglandins but that was unrelated to changes in blood flow at the 
site of stimulation. Whether the adrenergic axon reflex is induced by direct activation 
of neural 1-adrenoceptors or by stimulation of 1-adrenoceptors on other cutaneous   18 
cells (e.g., melanocytes or immune cells) (Kavelaars, 2002; Maestroni, 2006; Grando 
et al., 2006) requires further investigation. Adrenergic mediation of axon reflexes 
could contribute to aberrant sensory-sympathetic coupling in inflammatory diseases of 
the kidney and lower urinary tract (Kopp et al., 2007; Trevisani et al., 2007), and 
could exacerbate pain and inflammation after peripheral nerve and tissue injury 
(Birklein and Schmelz, 2008; Gibbs et al., 2008). Neuropeptides released from 
cutaneous nerves and other skin cells fine-tune cutaneous immune responses involved 
in tissue maintenance and repair (Peters et al., 2006). Further studies are required to 
clarify the role of 1-adrenoceptors in these sensory-immune interactions, both for 
normal regulation and in disease. 
 
 
Acknowledgements 
This project was supported by the National Health and Medical Research Council of 
Australia. I wish to thank Ms Katie Brocx for expert technical assistance. 
   19 
 References 
Birklein, F., Schmelz, M., 2008. Neuropeptides, neurogenic inflammation and 
complex regional pain syndrome (CRPS). Neurosci. Lett. 437, 199-202. 
Breternitz, M., Kowatzki, D., Langenauer, M., Elsner, P., Fluhr, J.W., 2008. Placebo-
controlled, double-blind, randomized, prospective study of a glycerol-based 
emollient on eczematous skin in atopic dermatitis: biophysical and clinical 
evaluation. Skin Pharmacol. Physiol. 21, 39-45. 
Charkoudian, N., 2001. Influences of female reproductive hormones on sympathetic 
control of the circulation in humans. Clin. Auton Res. 11, 295-301. 
Clough, G.F., 1999. Role of nitric oxide in the regulation of microvascular perfusion 
in human skin in vivo. J. Physiol. 516 ( Pt 2), 549-57. 
Drummond, P.D., 1995. Noradrenaline increases hyperalgesia to heat in skin 
sensitized by capsaicin. Pain 60, 311-5. 
Drummond, P.D., 1998. Enhancement of thermal hyperalgesia by alpha-adrenoceptors 
in capsaicin-treated skin. J. Auton. Nerv. Syst. 69, 96-102. 
Drummond, P.D., 1999. Nitroprusside inhibits thermal hyperalgesia induced by 
noradrenaline in capsaicin-treated skin. Pain 80, 405-12. 
Drummond, P.D., 2002. Prior iontophoresis of saline enhances vasoconstriction to 
phenylephrine and clonidine in the skin of the human forearm. Br. J. Clin. 
Pharmacol. 54, 45-50.  
Drummond, P.D., 2008. Depletion of noradrenaline inhibits electrically-evoked pain 
in the skin of the human forearm. Eur. J. Pain 12, 196-202. 
Drummond, P.D., 2009a. alpha(1)-Adrenoceptors augment thermal hyperalgesia in 
mildly burnt skin. Eur. J. Pain 13, 273-9. 
Drummond, P.D., 2009b. Alpha-1 adrenoceptor stimulation triggers axon-reflex   20 
vasodilatation in human skin. Auton. Neurosci. 151, 159-63. 
Drummond, P.D., Lipnicki, D.M., 1999. Noradrenaline provokes axon reflex 
hyperaemia in the skin of the human forearm. J. Auton. Nerv. Syst. 77, 39-44. 
Durand, S., Fromy, B., Bouye, P., Saumet, J.L, Abraham, P., 2002. Current-induced 
vasodilation during water iontophoresis (5 min, 0.10 mA) is delayed from current 
onset and involves aspirin sensitive mechanisms. J. Vasc. Res. 39, 59-71. 
Elam, M., Olausson, B., Skarphedinsson, J.O, Wallin, B.G., 1999. Does sympathetic 
nerve discharge affect the firing of polymodal C-fibre afferents in humans? 
Brain 122 ( Pt 12), 2237-44.  
Eisenach, J.C., Zhang, Y., Duflo, F., 2005. alpha2-adrenoceptors inhibit the 
intracellular Ca2+ response to electrical stimulation in normal and injured 
sensory neurons, with increased inhibition of calcitonin gene-related peptide 
expressing neurons after injury. Neurosci.131, 189-97. 
Ferrell, W.R., Ramsay, J.E., Brooks, N., Lockhart, J.C., Dickson, S., McNeece, G.M., 
Greer, I.A, Sattar, N., 2002. Elimination of electrically induced iontophoretic 
artefacts: implications for non-invasive assessment of peripheral microvascular 
function. J. Vasc. Res. 39, 447-55.  
Forster, C., Greiner, T., Nischik, M., Schmelz, M., Handwerker, H.O., 1995. 
Neurogenic flare responses are heterogeneous in superficial and deep layers of 
human skin. Neurosci. Lett. 185, 33-6. 
Fuchs, P.N., Meyer, R.A., Raja, S.N., 2001. Heat, but not mechanical hyperalgesia, 
following adrenergic injections in normal human skin. Pain 90, 15-23. 
Garry, M.G., Richardson, J.D., Hargreaves, K.M., 1994. Sodium nitroprusside evokes 
the release of immunoreactive calcitonin gene-related peptide and substance P 
from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent   21 
mechanisms. J. Neurosci. 14, 4329-37. 
Gibbs, G.F., Drummond, P.D., Finch, P.M., Phillips, J.K., 2008. Unravelling the 
pathophysiology of complex regional pain syndrome: focus on sympathetically 
maintained pain. Clin. Exp. Pharmacol. Physiol. 35, 717-24. 
Gozariu, M., Bustamante, D., Le Bars, D., Willer, J.C., 1996. Effects of clonidine on a 
C-fibre reflex in the rat. Eur. J. Pharmacol. 313, 51-62.  
Grando, S.A., Pittelkow, M.R., Schallreuter, K.U., 2006. Adrenergic and cholinergic 
control in the biology of epidermis: physiological and clinical significance. J. 
Invest. Dermatol. 126, 1948-65. 
Hersh, E.V., Moore, P.A., Ross, G.L., 2000. Over-the-counter analgesics and 
antipyretics: a critical assessment. Clin. Ther. 22, 500-48. 
Hodges, G.J., Kosiba, W.A., Zhao, K., Johnson, J.M., 2008. The involvement of 
norepinephrine, neuropeptide Y, and nitric oxide in the cutaneous vasodilator 
response to local heating in humans. J. Appl. Physiol. 105, 233-40. 
Hodges, G.J., Kosiba, W.A., Zhao, K., Johnson, J.M., 2009. The involvement of 
heating rate and vasoconstrictor nerves in the cutaneous vasodilator response to 
skin warming. Am. J. Physiol. Heart Circ. Physiol. 296, H51-6. 
Holden, J.E., Schwartz, E.J., Proudfit, H.K., 1999. Microinjection of morphine in the 
A7 catecholamine cell group produces opposing effects on nociception that are 
mediated by alpha1- and alpha2-adrenoceptors. Neuroscience 91, 979-90. 
Houghton, B.L., Meendering, J.R., Wong, B.J., Minson, C.T., 2006. Nitric oxide and 
noradrenaline contribute to the temperature threshold of the axon reflex response 
to gradual local heating in human skin. J. Physiol. 572, 811-20.  
Kavelaars, A., 2002. Regulated expression of alpha-1 adrenergic receptors in the 
immune system. Brain Behav. Immun. 16, 799-807.   22 
Khan, F., Newton, D.J., Smyth, E.C., Belch, J.J., 2004. Influence of vehicle resistance 
on transdermal iontophoretic delivery of acetylcholine and sodium nitroprusside 
in humans. J. Appl. Physiol. 97, 883-7.  
Kinnman, E., Levine, J.D., 1995. Involvement of the sympathetic postganglionic 
neuron in capsaicin-induced secondary hyperalgesia in the rat. Neurosci. 65, 283-
91. 
Kopp, U.C., Cicha, M.Z., Smith, L.A., Mulder, J., Hokfelt, T., 2007. Renal 
sympathetic nerve activity modulates afferent renal nerve activity by PGE2-
dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve 
fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1561-72. 
Lin, C.R., Amaya, F., Barrett, L., Wang, H., Takada, J., Samad, T.A., Woolf, C.J., 
2006. Prostaglandin E2 receptor EP4 contributes to inflammatory pain 
hypersensitivity. J. Pharmacol. Exp. Ther. 319, 1096-103. 
Lin, Q., Zou, X., Fang, L., Willis, W.D., 2003. Sympathetic modulation of acute 
cutaneous flare induced by intradermal injection of capsaicin in anesthetized rats. 
J. Neurophysiol. 89, 853-61. 
Lindgren, B.R., Anderson, C.D., Frodin, T., Andersson, R.G., 1987. Inhibitory effects 
of clonidine on allergic reactions in guinea-pig skin. Eur. J. Pharmacol. 134, 339-
43. 
Lipnicki, D.M., Drummond, P.D., 2001. Facilitating laser Doppler measurements of 
cutaneous adrenergic vasoconstriction: a comparison of methods. Clin. Auton. 
Res. 11, 93-8. 
Machen, J., Whitefield, M., 2002. Efficacy of a proprietary ibuprofen gel in soft tissue 
injuries: a randomised, double-blind, placebo-controlled study. Int. J. Clin. Pract. 
56, 102-6.    23 
Maestroni, G.J., 2006. Sympathetic nervous system influence on the innate immune 
response. Ann. N. Y. Acad. Sci. 1069: 195-207. 
McCormack, K., Kidd, B.L., Morris, V., 2000. Assay of topically administered 
ibuprofen using a model of post-injury hypersensitivity. A randomised, double-
blind, placebo-controlled study. Eur. J. Clin. Pharmacol. 56, 459-62. 
Meisner, J.G., Waldron, J.B., Sawynok, J., 2007. Alpha1-adrenergic receptors 
augment P2X3 receptor-mediated nociceptive responses in the uninjured state. J. 
Pain 8, 556-62. 
Minson, C.T., Holowatz, L.A., Wong, B.J., Kenney, W.L., Wilkins, B.W., 2002. 
Decreased nitric oxide- and axon reflex-mediated cutaneous vasodilation with age 
during local heating. J. Appl. Physiol. 93, 1644-9. 
Morris, S.J., Shore, A.C., 1996. Skin blood flow responses to the iontophoresis of 
acetylcholine and sodium nitroprusside in man: possible mechanisms. J. Physiol. 
496 ( Pt 2), 531-42. 
Neisius, U., Olsson, R., Rukwied, R., Lischetzki, G., Schmelz, M., 2002. 
Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation 
in atopic dermatitis and controls. J. Am. Acad. Dermatol. 47, 28-32. 
Nicholson, R., Dixon, A.K., Spanswick, D., Lee, K., 2005. Noradrenergic receptor 
mRNA expression in adult rat superficial dorsal horn and dorsal root ganglion 
neurons. Neurosci. Lett. 380, 316-21. 
Pertovaara, A., 2006. Noradrenergic pain modulation. Prog. Neurobiol. 80, 53-83. 
Peters, E.M., Ericson, M.E., Hosoi, J., Seiffert, K., Hordinsky, M.K., Ansel, J.C., 
Paus, R., Scholzen, T.E., 2006. Neuropeptide control mechanisms in cutaneous 
biology: physiological and clinical significance. J. Invest. Dermatol. 126, 1937-
47.   24 
Ren, Y., Zou, X., Fang, L., Lin, Q., 2005. Sympathetic modulation of activity in 
Adelta- and C-primary nociceptive afferents after intradermal injection of 
capsaicin in rats. J. Neurophysiol. 93, 365-77. 
Richardson, J.D., Vasko, M.R., 2002. Cellular mechanisms of neurogenic 
inflammation. J. Pharmacol. Exp. Ther. 302, 839-45. 
Sato, J., Perl, E.R., 1991. Adrenergic excitation of cutaneous pain receptors induced 
by peripheral nerve injury. Science 251, 1608-10. 
Schmelz, M., Petersen, L.J., 2001. Neurogenic inflammation in human and rodent 
skin. News Physiol. Sci. 16, 33-7.  
Schmelz, M. Michael, K., Weidner, C., Schmidt, R., Torebjork, H.E., Handwerker, 
H.O., 2000. Which nerve fibers mediate the axon reflex flare in human skin? 
Neuroreport, 11, 645-8. 
Shibasaki, M., Low, D.A., Davis, S.L., Crandall, C.G., 2008. Nitric oxide inhibits 
cutaneous vasoconstriction to exogenous norepinephrine. J. Appl. Physiol. 105, 
1504-8. 
Tartas, M., Bouye, P., Koitka, A., Durand, S., Gallois, Y., Saumet, J.L., Abraham, P., 
2005. Early vasodilator response to anodal current application in human is not 
impaired by cyclooxygenase-2 blockade. Am. J. Physiol. Heart Circ. Physiol. 
288, H1668-73. 
Tegeder, I., Muth-Selbach, U., Lotsch, J., Rusing, G., Oelkers, R., Brune, K., Meller, 
S., Kelm, G.R., Sorgel, F., Geisslinger, G., 1999. Application of microdialysis for 
the determination of muscle and subcutaneous tissue concentrations after oral and 
topical ibuprofen administration. Clin. Pharmacol. Ther. 65, 357-68. 
Thompson, C.S., Holowatz, L.A., Kenney, W.L., 2005. Attenuated noradrenergic 
sensitivity during local cooling in aged human skin. J. Physiol. 564, 313-9.   25 
Trevisani, M., Campi, B., Gatti, R., Andre, E., Materazzi, S., Nicoletti, P., Gazzieri, 
D., Geppetti, P., 2007. The influence of alpha1-adrenoreceptors on neuropeptide 
release from primary sensory neurons of the lower urinary tract. Eur. Urol. 52, 
901-8. 
Turner, J., Belch, J.J., Khan, F., 2008. Current concepts in assessment of 
microvascular endothelial function using laser Doppler imaging and 
iontophoresis. Trends Cardiovasc. Med. 18, 109-16. 
Tuttle, J.B., Etheridge, R., Creedon, D.J., 1993. Receptor-mediated stimulation and 
inhibition of nerve growth factor secretion by vascular smooth muscle. Exp. Cell 
Res. 208, 350-61. 
Zahn, S., Leis, S., Schick, C., Schmelz, M., Birklein, F., 2004. No alpha-
adrenoreceptor-induced C-fiber activation in healthy human skin. J. Appl. 
Physiol. 96, 1380-4.   26 
Table 1 
Pain ratings (range 0-10) during the iontophoresis of phenylephrine and saline-control 
at sites pretreated with the ibuprofen or conductive gel (N = 14) 
  Pain Rating + S.E. during Iontophoresis 
  Phenylephrine  Saline 
Pretreatment     
Ibuprofen gel  2.0 + 0.5  2.1 + 0.5 
Conductive gel  2.5 + 0.6  2.9 + 0.6 
   27 
Figure legends 
Figure 1. Change in flux (+ S.E., N = 9) (A) at the site of iontophoresis of saline, 
phenylephrine and clonidine (350 µA for 3 minutes), and (B) 8 mm from the site of 
iontophoresis. Responses are expressed as the percent change from levels recorded 
immediately before the iontophoreses. Axon reflex vasodilatation to phenylephrine 
was significantly greater than the response to saline (* p<0.05). 
Figure 2. Change in flux (+ S.E., N = 14) at the site of iontophoresis of (A) 
phenylephrine (350 µA for 3 minutes) and (B) saline (350 µA for 3 minutes) after 
pretreatment with the ibuprofen or conductive gel (control). The ibuprofen 
pretreatment inhibited vasodilatation at sites of phenylephrine and saline 
iontophoresis (* p<0.05). 
Figure 3. Change in flux (+ S.E.) 8 mm from the site of iontophoresis of (A) 
phenylephrine (350 µA for 3 minutes, N = 13) and (B) saline (350 µA for 3 minutes, 
N = 14) after pretreatment with the ibuprofen or conductive gel (control). The 
ibuprofen pretreatment inhibited vasodilatation 8 mm from the site of phenylephrine 
iontophoresis (* p<0.05). 
Figure 4. Change in flux (+ S.E., N = 9) after the iontophoresis of phenylephrine (350 
µA for 3 minutes) (A) at sites pretreated with local anaesthetic cream (EMLA), 
sorbolene cream or no pretreatment. The direct response to phenylephrine was 
significantly smaller at sites pretreated with EMLA or sorbolene than at the untreated 
site (* p<0.05). (B) Responses were also monitored 8 mm from sites of phenylephrine 
iontophoresis. Responses were expressed as the percent change from levels recorded 
immediately before the phenylephrine iontophoreses. Axon reflex vasodilatation to 
phenylephrine was significantly greater at untreated sites and sites pretreated with 
sorbolene than at sites pretreated with EMLA (* p<0.05).   28 
Figure 5. Change in flux (+ S.E., N = 8) (A) after the iontophoresis of nitroprusside 
and saline-control (50 µA for 2 minutes) at the site of iontophoresis. The direct 
response to nitroprusside was significantly greater than the response to saline (* 
p<0.001). (B) Responses were also monitored 8 mm from sites of nitroprusside 
iontophoresis. 
Figure 6. Change in flux (+ S.E., N = 8) (A) after the iontophoresis of phenylephrine 
(350 µA for 3 minutes) at sites pretreated with nitroprusside or saline-control (50 µA 
for 2 minutes), and (B) at sites 8 mm away. Responses were expressed as the percent 
change from levels recorded immediately before the initial nitroprusside or saline 
pretreatments. Flux decreased during the iontophoresis of phenylphrine at the site 
pretreated with nitroprusside but increased at the site pretreated with saline (* 
difference between sites statistically significant, p<0.05). 
Figure 7. Change in flux (+ S.E., N = 9) (A) after the iontophoresis of nitroprusside or 
saline-control (50 µA for 2 minutes) at sites pretreated with phenylephrine (350 µA 
for 3 minutes), and (B) at sites 8 mm away. Responses were expressed as the percent 
change from levels recorded immediately before the initial phenylephrine 
pretreatments. Note that flux increased approximately 500% above baseline in the 
region of axon reflex vasodilatation during the prior iontophoresis of phenylephrine, 
but did not change further during the iontophoresis of nitroprusside or saline.  29 
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3A. response to phenylephrine
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4A. response to phenylephrine
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5A. response at drug administration site
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6A. response to phenylephrine
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7A. response at drug administration site
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